Abstract
Vitamin A and its derivatives have been shown to modulate the immune system via retinoic acid receptor (RAR). This study explored the impact of retinyl palmitate supplementation on RAR subtype gene expression in peripheral blood mononuclear cells (PBMCs) in multiple sclerosis (MS) patients. The study designed as a double-blind randomized clinical trial in which relapsing remitting multiple sclerosis patients were evaluated. Both groups received one capsule 50,000 IU vitamin D3 per 2 weeks and one intramuscular injection interferon beta-1a per week. The intervention group received one 25,000 IU retinyl palmitate capsule daily for 6 months and the placebo group received one placebo capsule daily. The PBMCs were isolated from participants and the expression level changes of RAR-α and RAR-γ genes were determined by real-time PCR. After supplementation, in the intervention group, the RAR-α gene expression level was significantly decreased compared to the placebo group (p = 0.03); however, the expression of RAR-γ gene did not significantly change (p = 0.10). These results show that vitamin A supplementation can significantly downregulate the expression of RAR-α gene in PBMCs of MS patients that suggest the presence of in vivo regulatory mechanisms for the action of vitamin A on the immune system.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alberts D, Ranger-Moore J et al (2004) Safety and efficacy of dose-intensive oral vitamin A in subjects with sun-damaged skin. Clin Cancer Res 10(6):1875–1880
Aranami T, Yamamura T (2008) Th17 cells and autoimmune encephalomyelitis (EAE/MS). Allergol Int 57(2):115–120
Ballow M, Wang X et al (2003) Expression and regulation of nuclear retinoic acid receptors in human lymphoid cells. J Clin Immunol 23(1):46–54
Dollé P (2009) Developmental expression of retinoic acid receptors (RARs). Nucl Recep Signal 7:e006
Feart C, Pallet V et al (2005) Aging affects the retinoic acid and the triiodothyronine nuclear receptor mRNA expression in human peripheral blood mononuclear cells. Eur J Endocrinol 152(3):449–458
Gjøen T, Bjerkelund T et al (1987) Liver takes up retinol-binding protein from plasma. J Biol Chem 262(23):10926–10930
Green S, Chambon P (1988) Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 4(11):309–314
Gudas LJ, Sporn MB et al (1994) Cellular biology and biochemistry of the retinoids. The Retinoids: Biology, Chemistry, and Medicine 1994:443–520
Halevy O, Arazi Y et al (1994) Retinoic acid receptor-alpha gene expression is modulated by dietary vitamin A and by retinoic acid in chicken T lymphocytes. J Nutr 124(11):2139–2146
Heller J (1975) Interactions of plasma retinol-binding protein with its receptor. Specific binding of bovine and human retinol-binding protein to pigment epithelium cells from bovine eyes. J Biol Chem 250(10):3613–3619
Holmøy T, Hestvik ALK (2008) Multiple sclerosis: immunopathogenesis and controversies in defining the cause. Curr Opin Infect Dis 21(3):271–278
Honarvar NM, Harirchian MH et al (2013) The effect of vitamin a supplementation on retinoic acid-related orphan receptor γt (RORγt) and interleukin-17 (IL-17) gene expression in avonex-treated multiple sclerotic patients. J Mol Neurosci 1–5
Idres N, Marill J et al (2002) Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers. J Biol Chem 277(35):31491–31498
Iwata M, Eshima Y et al (2003) Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int Immunol 15(8):1017–1025
Jafarirad S, Siassi F et al (2012a) The effect of vitamin a supplementation on biochemical parameters in multiple sclerosis patients. Iranian Red Cresc Med J 15(3):194–198
Jafarirad S, Siassi F et al (2012b) The effect of vitamin A supplementation on stimulated T-cell proliferation with myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. J Neurosci Rural Pract 3(3):294–298
Lefebvre P, Benomar Y et al (2010) Retinoid X receptors: common heterodimerization partners with distinct functions. Trends Endocrinol Metab 21(11):676–683
Lovett-Racke AE, Racke MK (2002) Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cells. Cell Immunol 215(1):54–60
Marill J, Cresteil T et al (2000) Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol 58(6):1341–1348
Mottaghi A, Salehi E, Sezavar H et al (2013) The influence of vitamin A supplementation on Foxp3 and TGF gene expression in atherosclerosis patients. J Nutrigenet Nutrigenomics 5(6):314–326
Park EY, Dillard A et al (2005) Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism. Cancer Res 65(21):9923–9933
Qu ZX, Pliskin N et al (2001) Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis. Arch Neurol 58(1):87–90
Racke MK, Bonomo A et al (1994) Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180(5):1961–1966
Racke MK, Burnett D et al (1995) Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 154(1):450–458
Rhinn M, Dollé P (2012) Retinoic acid signalling during development. Development 139(5):843–858
Sedjo RL, Ranger-Moore J et al (2004) Circulating endogenous retinoic acid concentrations among participants enrolled in a randomized placebo-controlled clinical trial of retinyl palmitate. Cancer Epidemiol Biomark Prev 13(11):1687–1692
Semba RD (1998) The role of vitamin A and related retinoids in immune function. Nutr Rev 56(1):S38–S48
Szabova L, Macejova D et al (2003) Expression of nuclear retinoic acid receptor in peripheral blood mononuclear cells (PBMC) of healthy subjects. Life Sci 72(7):831–836
Szondy Z, Reichert U et al (1997) Induction of apoptosis by retinoids and retinoic acid receptor γ-selective compounds in mouse thymocytes through a novel apoptosis pathway. Mol Pharmacol 51(6):972–982
Szondy Z, Reichert U et al (1998a) Inhibition of activation-induced apoptosis of thymocytes by all-trans-and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha. Biochem J 331(Pt 3):767–774
Szondy Z, Reichert U et al (1998b) Retinoic acids regulate apoptosis of T lymphocytes through an interplay between RAR and RXR receptors. Cell Death Differ 5(1):4–10
Verma AK, Shoemaker A et al (1992) Expression of retinoic acid nuclear receptors and tissue transglutaminase is altered in various tissues of rats fed a vitamin A-deficient diet. J Nutr 122(11):2144–2152
Warrell RP Jr, Frankel SR et al (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). New England J Med 324(20):1385–1393
Xiao S, Jin H et al (2008) Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-β-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 181(4):2277–2284
Acknowledgment
We wish to thank the Tehran University of Medical Sciences (TUMS) and Health Services grants with number of 91-03-161-19476, and Iranian Center for Neurological Research.
Conflict of interest
The authors declare that there is no conflict of interest in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bitarafan, S., Harirchian, M.H., Sahraian, M.A. et al. Impact of Vitamin A Supplementation on RAR Gene Expression in Multiple Sclerosis Patients. J Mol Neurosci 51, 478–484 (2013). https://doi.org/10.1007/s12031-013-0090-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-013-0090-9